Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 27, Issue 12, Pages 2144-2153
Publisher
Springer Science and Business Media LLC
Online
2021-10-26
DOI
10.1038/s41591-021-01556-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Thrombocytopenia in a 22‐Year‐Old Post Covid‐19 Vaccine
- (2021) Omar H. Tarawneh et al. AMERICAN JOURNAL OF HEMATOLOGY
- Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination
- (2021) Eun‐Ju Lee et al. AMERICAN JOURNAL OF HEMATOLOGY
- In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose
- (2021) Zain Chagla ANNALS OF INTERNAL MEDICINE
- Bell’s palsy following COVID-19 vaccination
- (2021) Giuseppe Colella et al. JOURNAL OF NEUROLOGY
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations
- (2021) Nicholas G. Kounis et al. Vaccines
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
- (2021) Eleftheria Vasileiou et al. LANCET
- Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
- (2021) Cristina Menni et al. LANCET INFECTIOUS DISEASES
- COVID-19 vaccination-associated myelitis
- (2021) Hardeep Singh Malhotra et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
- (2021) Anton Pottegård et al. BMJ-British Medical Journal
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
- (2021) Jamie Lopez Bernal et al. BMJ-British Medical Journal
- Guillain‐Barré Syndrome following ChAdOx1‐S / nCoV ‐19 Vaccine
- (2021) Boby V. Maramattom et al. ANNALS OF NEUROLOGY
- Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination
- (2021) Christopher Martin Allen et al. ANNALS OF NEUROLOGY
- Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
- (2021) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- (2020) Ross W Paterson et al. BRAIN
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Self controlled case series methods: an alternative to standard epidemiological study designs
- (2016) Irene Petersen et al. BMJ-British Medical Journal
- Self controlled case series methods: an alternative to standard epidemiological study designs
- (2016) Irene Petersen et al. BMJ-British Medical Journal
- Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study
- (2014) Alastair J S Webb et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Drug safety studies and measures of effect using the self-controlled case series design
- (2012) Kumanan Wilson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Negative Controls
- (2010) Marc Lipsitch et al. EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started